Paper12464801
Haplotype structure of the UDP-glucuronosyltransferase 1A1 promoter in different ethnic groups.
Innocenti F and 7 others. Pharmacogenetics, 2002. Cited by 141 papers, by iCite.
Cite this record
ConductScience Library. Haplotype structure of the UDP-glucuronosyltransferase 1A1 promoter in different ethnic groups. Papers, record 12464801. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/12464801
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Haplotype structure of the UDP-glucuronosyltransferase 1A1 promoter in different ethnic groups.
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Camptothecin | Major topic |
| Glucuronosyltransferase | Major topic |
| Microsomes, Liver | Major topic |
| Polymorphism, Genetic | Major topic |
| Promoter Regions, Genetic | Major topic |
| Black or African American | |
| Base Sequence | |
| Bilirubin | |
| Genotype | |
| Glucuronides | |
| Haplotypes | |
| Humans | |
| Irinotecan | |
| Linkage Disequilibrium | |
| Molecular Sequence Data | |
| Phenobarbital | |
| Topoisomerase I Inhibitors | |
| White People | |
| UGT1A1 Enzyme |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| GM61393 | NIGMS NIH HHS | United States | U01GM061393 | PubMed and NIH | NIH RePORTER |
| U01-GM61374 | NIGMS NIH HHS | United States | U01GM061374 | PubMed and NIH | NIH RePORTER |
Cited by49
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 141 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41304835 | The Association Between Genetic Polymorphisms of UGT1A1, ABCG2, and NR1I2 and Dolutegravir Pharmacokinetic Parameters in Thai People Living with HIV. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/41304835 | PubMed |
| 40143136 | Managing Irinotecan-Induced Diarrhea: A Comprehensive Review of Therapeutic Interventions in Cancer Treatment. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/40143136 | PubMed |
| 38682893 | Assessing Pharmacogenomic loci Associated with the Pharmacokinetics of Vamorolone in Boys with Duchenne Muscular Dystrophy. | J Clin Pharmacol | 2024 | https://conductscience.org/library/papers/38682893 | PubMed |
| 36778023 | PAnno: A pharmacogenomics annotation tool for clinical genomic testing. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/36778023 | PubMed |
| 35942604 | Bilirubin metabolism and UDP-glucuronosyltransferase 1A1 variants in Asians: Pathogenic implications and therapeutic response. | Kaohsiung J Med Sci | 2022 | https://conductscience.org/library/papers/35942604 | PubMed |
| 35205356 | Pharmacogenetics of Drugs Used in the Treatment of Cancers. | Genes (Basel) | 2022 | https://conductscience.org/library/papers/35205356 | PubMed |
| 34860573 | All You Need to Know About UGT1A1 Genetic Testing for Patients Treated With Irinotecan: A Practitioner-Friendly Guide. | JCO Oncol Pract | 2022 | https://conductscience.org/library/papers/34860573 | PubMed |
| 32821392 | Application of pharmacogenetics in oncology. | Biomark Res | 2020 | https://conductscience.org/library/papers/32821392 | PubMed |
| 32019188 | Comparison of Eight Technologies to Determine Genotype at the UGT1A1 (TA)n Repeat Polymorphism: Potential Clinical Consequences of Genotyping Errors? | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32019188 | PubMed |
| 30669780 | [Clinical diagnosis of genetic liver disease]. | Zhonghua Gan Zang Bing Za Zhi | 2018 | https://conductscience.org/library/papers/30669780 | PubMed |
| 29520731 | Individualization of Irinotecan Treatment: A Review of Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics. | Clin Pharmacokinet | 2018 | https://conductscience.org/library/papers/29520731 | PubMed |
| 28620445 | Unusual gastrointestinal and cutaneous toxicities by bleomycin, etoposide, and cisplatin: a case report with pharmacogenetic analysis to personalize treatment. | EPMA J | 2017 | https://conductscience.org/library/papers/28620445 | PubMed |
| 28594959 | Reduced total serum bilirubin levels are associated with ulcerative colitis. | PLoS One | 2017 | https://conductscience.org/library/papers/28594959 | PubMed |
| 28567595 | Do Alpha Thalassemia, Fetal Hemoglobin, and the UGT1A1 Polymorphism have an Influence on Serum Bilirubin Levels and Cholelithiasis in Patients with Sickle Cell Disease? | Mol Diagn Ther | 2017 | https://conductscience.org/library/papers/28567595 | PubMed |
| 28213806 | Clinical UGT1A1 Genetic Analysis in Pediatric Patients: Experience of a Reference Laboratory. | Mol Diagn Ther | 2017 | https://conductscience.org/library/papers/28213806 | PubMed |
| 27978934 | [The analysis of UGT1A1 gene mutations in hereditary unconjugated hyperbilirubinemia]. | Zhonghua Gan Zang Bing Za Zhi | 2016 | https://conductscience.org/library/papers/27978934 | PubMed |
| 27767376 | Pharmacogenomics and histone deacetylase inhibitors. | Pharmacogenomics | 2016 | https://conductscience.org/library/papers/27767376 | PubMed |
| 26773202 | UGT genotyping in belinostat dosing. | Pharmacol Res | 2016 | https://conductscience.org/library/papers/26773202 | PubMed |
| 26637161 | UGT1A1 genotype-dependent dose adjustment of belinostat in patients with advanced cancers using population pharmacokinetic modeling and simulation. | J Clin Pharmacol | 2016 | https://conductscience.org/library/papers/26637161 | PubMed |
| 26313268 | Effects of UGT1A1 genotype on the pharmacokinetics, pharmacodynamics, and toxicities of belinostat administered by 48-hour continuous infusion in patients with cancer. | J Clin Pharmacol | 2016 | https://conductscience.org/library/papers/26313268 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| UGT1A1 | 54658 | PubTator's text mining | https://conductscience.org/library/genes/54658 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/12464801
GET https://conductscience.org/api/papers/v1/12464801/cited_by?page=2